CERO — CERo Therapeutics Holdings Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for CERo Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 6.82 | 1.6 | 3.33 | 1.59 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 7.08 | 1.97 | 3.71 | 2.73 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 4.27 | 3.16 | 1.99 | 0.907 |
| Other Long Term Assets | ||||
| Total Assets | 11.3 | 5.13 | 6.21 | 3.64 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1.16 | 3.51 | 7.4 | 9.09 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 4.12 | 5.08 | 8.1 | 9.09 |
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 7.23 | 0.044 | -1.89 | -5.45 |
| Total Liabilities & Shareholders' Equity | 11.3 | 5.13 | 6.21 | 3.64 |
| Total Common Shares Outstanding | ||||
| Total Preferred Shares Outstanding |